|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/135 | |
| A61K 47/26 | |||
| A61P 25/16 |
| (11) | Patento numeris | 1827409 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05851829.1 |
| Europos patento paraiškos padavimo data | 2005-11-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-09-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-08-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/041882 |
| Data | 2005-11-17 |
| (87) | Numeris | WO 2006/057912 |
| Data | 2006-06-01 |
| (30) | Numeris | Data | Šalis |
| 630918 P | 2004-11-24 | US | |
| 997785 | 2004-11-24 | US |
| (72) |
PATASHNIK, Shulamit, IL
LICHT, Daniella, IL
GILBERT, Adrian, IL
|
| (73) |
TEVA PHARMACEUTICAL INDUSTRIES, LTD.,
5 Basel Street, P.O. Box 3190, 49131 Petach-Tikva,
IL
|
| (54) | RASAGILINE ORALLY DISINTEGRATING COMPOSITIONS |
| RASAGILINE ORALLY DISINTEGRATING COMPOSITIONS |